
MNKD
Healthcare · Biotechnology · $1.33B market cap
$4.13-0.03 (-0.7%)Nov 13, 4:00 PM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · -9.3% over 90 days · 30-day revisions 1 up, 1 down
Beat estimates in 1 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 5, 2026 | After the close | -0.08 | -0.07 | +12.5% |
| Aug 5, 2026 | After the close | -0.02 | -0.06 | -200.0% |
| May 7, 2026 | Time not confirmed | 0.01 | -0.02 | -398.5% |
| Feb 26, 2026 | Before the open | -0.01 | -0.05 | -400.0% |
| Nov 5, 2025 | Before the open | 0.01 | 0.03 | +200.0% |
| Aug 6, 2025 | Before the open | 0.08 | 0.05 | -37.5% |
| May 6, 2025 | Before the open | 0.06 | 0.04 | -33.3% |
| Feb 26, 2025 | After the close | 0.04 | 0.03 | -25.0% |
| Nov 7, 2024 | After the close | 0.03 | 0.04 | +33.3% |
| Aug 7, 2024 | Before the open | 0.01 | -0.01 | -200.0% |
| May 8, 2024 | After the close | 0.03 | 0.04 | +33.3% |
| Feb 27, 2024 | After the close | 0.01 | 0.00 | -57.0% |
| Nov 7, 2023 | After the close | -0.02 | 0.01 |
MannKind Corporation, a biopharmaceutical company, focuses on the provision of various solutions for transforming chronic disease care. It develops and commercializes treatments that address various unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease. The company's commercial products include Afrezza, an inhaled insulin used to improve…
| +150.0% |
| Aug 7, 2023 | After the close | -0.04 | -0.02 | +50.0% |
| May 9, 2023 | After the close | -0.05 | -0.04 | +20.0% |
| Feb 22, 2023 | Before the open | -0.06 | -0.07 | -16.7% |
| Nov 8, 2022 | Before the open | -0.08 | -0.06 | +25.0% |
| Aug 9, 2022 | After the close | -0.09 | -0.11 | -22.2% |
| May 5, 2022 | After the close | -0.10 | -0.10 | 0.0% |
| Feb 24, 2022 | After the close | -0.07 | -0.11 | -57.1% |
| Nov 9, 2021 | After the close | -0.08 | -0.04 | +50.0% |
| Aug 11, 2021 | After the close | -0.04 | -0.05 | -25.0% |
| May 12, 2021 | After the close | -0.05 | -0.05 | 0.0% |
| Feb 25, 2021 | Before the open | -0.04 | -0.06 | -50.0% |
| Nov 4, 2020 | After the close | -0.05 | -0.05 | 0.0% |
| Aug 5, 2020 | After the close | -0.06 | -0.05 | +16.7% |
| May 6, 2020 | After the close | -0.06 | -0.04 | +33.3% |
| Feb 25, 2020 | Before the open | -0.08 | -0.07 | +12.5% |
| Nov 6, 2019 | Before the open | -0.07 | -0.07 | 0.0% |
| Aug 7, 2019 | After the close | -0.08 | -0.07 | +12.5% |
| May 7, 2019 | Before the open | -0.13 | -0.08 | +38.5% |
| Feb 26, 2019 | Before the open | 0.22 | -0.06 | -127.3% |
| Nov 1, 2018 | Before the open | -0.18 | -0.15 | +16.7% |
| Aug 2, 2018 | After the close | -0.20 | -0.17 | +15.0% |
| May 9, 2018 | After the close | -0.23 | -0.25 | -8.7% |
| Feb 27, 2018 | After the close | -0.29 | -0.28 | +3.4% |